PSO-NET: Development of an Automated Psoriasis Assessment System Using Attention-Based Interpretable Deep Neural Networks

Psoriasis is a chronic skin condition that requires long-term treatment and monitoring. Although, the Psoriasis Area and Severity Index (PASI) is utilized as a standard measurement to assess psoriasis severity in clinical trials, it has many draw-backs such as (1) patient burden for in-person clinic visits for assessment of psoriasis, (2) time required for investigator scoring and (3) variability of inter-and intra-rater scoring. To address these drawbacks, we propose a novel and inter-pretable deep learning architecture called PSO-Net, which maps digital images from different anatomical regions to derive attention-based scores. Regional scores are further combined to estimate an absolute PASI score. Moreover, we devise a novel regression activation map for interpretability through ranking attention scores. Using this approach, we achieved inter-class correlation scores of 82.2% [95% CI: 77- 87%] and 87.8% [95% CI: 84–91%] with two different clinician raters, respectively.

Authors

Publication Details

Published
2025-04-14
DOI
https://doi.org/10.1109/isbi60581.2025.10980765
Citations
1
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
1.50
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PSO-NET: Development of an Automated Psoriasis Assessment System Using Attention-Based Interpretable Deep Neural Networks

Molly V. Lucas, Sophia C. Kamran, Gabriela Oana Cula, Atman P. Shah et al.
1 citations
Computational Drug Discovery Methods
1.50
article

PSO-NET: Development of an Automated Psoriasis Assessment System Using Attention-Based Interpretable Deep Neural Networks

Molly V. Lucas, Sophia C. Kamran, Gabriela Oana Cula, Atman P. Shah, Brendon Lutnick, Steven Fakharzadeh, Lloyd Miller, Stephen Yip, Chaitanya Parmar, Kristopher Standish, Basudha Pal, David Apfel
article en
1 citations

Abstract

Psoriasis is a chronic skin condition that requires long-term treatment and monitoring. Although, the Psoriasis Area and Severity Index (PASI) is utilized as a standard measurement to assess psoriasis severity in clinical trials, it has many draw-backs such as (1) patient burden for in-person clinic visits for assessment of psoriasis, (2) time required for investigator scoring and (3) variability of inter-and intra-rater scoring. To address these drawbacks, we propose a novel and inter-pretable deep learning architecture called PSO-Net, which maps digital images from different anatomical regions to derive attention-based scores. Regional scores are further combined to estimate an absolute PASI score. Moreover, we devise a novel regression activation map for interpretability through ranking attention scores. Using this approach, we achieved inter-class correlation scores of 82.2% [95% CI: 77- 87%] and 87.8% [95% CI: 84–91%] with two different clinician raters, respectively.

Openalex Percentile: Top 17%
Computational Drug Discovery Methods
1.50
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.